ARYX THERAPEUTICS Fundamentals

ARYX
 Stock
  

USD 0.0005  0.00  0.00%   

ARYX THERAPEUTICS INC fundamentals help investors to digest information that contributes to ARYX THERAPEUTICS's financial success or failures. It also enables traders to predict the movement of ARYX THERAPEUTICS Stock. The fundamental analysis module provides a way to measure ARYX THERAPEUTICS's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ARYX THERAPEUTICS stock.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  

ARYX THERAPEUTICS Shares Owned by Institutions Analysis

ARYX THERAPEUTICS's Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
Shares Held by Institutions 
 = 
Funds and Banks 
Firms 
More About Shares Owned by Institutions | All Equity Analysis

Current ARYX THERAPEUTICS Shares Owned by Institutions

    
  0.15 %  
Most of ARYX THERAPEUTICS's fundamental indicators, such as Shares Owned by Institutions, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ARYX THERAPEUTICS INC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Compare to competition

Based on the latest financial disclosure, 0.15% of ARYX THERAPEUTICS INC are shares owned by institutions. This is 99.66% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The shares owned by institutions for all United States stocks is 99.62% higher than that of the company.

ARYX THERAPEUTICS INC Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining ARYX THERAPEUTICS's current stock value. Our valuation model uses many indicators to compare ARYX THERAPEUTICS value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ARYX THERAPEUTICS competition to find correlations between indicators driving ARYX THERAPEUTICS's intrinsic value. More Info.
ARYX THERAPEUTICS INC is number one stock in short ratio category among related companies. It is the top company in total debt category among related companies making up about  14,645,570  of Total Debt per Short Ratio. . Comparative valuation analysis is a catch-all model that can be used if you cannot value ARYX THERAPEUTICS by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for ARYX THERAPEUTICS's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ARYX THERAPEUTICS's earnings, one of the primary drivers of an investment's value.

Did you try this?

Run CEO Directory Now

   

CEO Directory

Screen CEOs from public companies around the world
All  Next Launch Module

ARYX THERAPEUTICS Fundamentals

About ARYX THERAPEUTICS Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze ARYX THERAPEUTICS INC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ARYX THERAPEUTICS using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ARYX THERAPEUTICS INC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
ARYx Therapeutics, Inc. discovers and develops novel therapies for large, chronic, and oral markets. ARYx Therapeutics, Inc. was founded in 1997 and is based in Fremont, California. Aryx Therapeutics operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 56 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in ARYX THERAPEUTICS without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Technical Analysis Now

   

Technical Analysis

Check basic technical indicators and analysis based on most latest market data
All  Next Launch Module

Pair Trading with ARYX THERAPEUTICS

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ARYX THERAPEUTICS position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ARYX THERAPEUTICS will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to ARYX THERAPEUTICS could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ARYX THERAPEUTICS when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ARYX THERAPEUTICS - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ARYX THERAPEUTICS INC to buy it.
The correlation of ARYX THERAPEUTICS is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ARYX THERAPEUTICS moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ARYX THERAPEUTICS INC moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ARYX THERAPEUTICS can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Please continue to Trending Equities. You can also try Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Tools for ARYX THERAPEUTICS Stock

When running ARYX THERAPEUTICS INC price analysis, check to measure ARYX THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ARYX THERAPEUTICS is operating at the current time. Most of ARYX THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of ARYX THERAPEUTICS's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move ARYX THERAPEUTICS's price. Additionally, you may evaluate how the addition of ARYX THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go